Park Ha Biological Technology Co., Ltd. (BYAH): EBITDA
-$24.04M
Year ended 2025-10-31
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-10-31 | -$24.04M | n/m | 2026-05-15, From 2024-11-01 |
| 2024-10-31 | $816.4K | -32.0% | 2026-05-15, From 2023-11-01 |
| 2023-10-31 | $1.20M | +427.7% | 2026-05-15, From 2022-11-01 |
| 2022-10-31 | $227.5K | n/a | 2025-02-24, From 2021-11-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Park Ha Biological Technology Co., Ltd. (BYAH) | 2025-10-31 | -$24.04M | n/m |
| Longevity Health Holdings, Inc. (XAGE) | 2025-12-31 | -$7.03M | n/m |
| Meiwu Technology Co Ltd (WNW) | 2025-12-31 | -$5.90M | n/m |
| Stepan Co (SCL) | 2025-12-31 | $204.59M | +12.0% |
| Church & Dwight Co Inc (CHD) | 2025-12-31 | $1.32B | +26.6% |
| Procter & Gamble Co (PG) | 2026-06-30 | $22.91B | -1.7% |
Compare BYAH, XAGE, WNW, SCL side by side · Screen every company in Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics ↗